These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 6274572

  • 1. Effects of the oral angiotensin-converting enzyme inhibitor MK-421 in human hypertension.
    Gavras H, Biollaz J, Waeber B, Brunner HR, Gavras I, Sackel H, Charocopos F, Davies RO.
    Clin Sci (Lond); 1981 Dec; 61 Suppl 7():281s-283s. PubMed ID: 6274572
    [Abstract] [Full Text] [Related]

  • 2. Effects of the new oral angiotensin converting enzyme inhibitor MK-421 in human hypertension.
    Gavras H, Biollaz J, Waeber B, Brunner HR, Gavras I, Davies RO.
    Clin Exp Hypertens A; 1982 Dec; 4(1-2):303-14. PubMed ID: 6280900
    [Abstract] [Full Text] [Related]

  • 3. Antihypertensive effect of the new oral angiotensin converting enzyme inhibitor "MK-421".
    Gavras H, Biollaz J, Waeber B, Brunner HR, Gavras I, Davies RO.
    Lancet; 1981 Sep 12; 2(8246):543-7. PubMed ID: 6116000
    [Abstract] [Full Text] [Related]

  • 4. [The acute effects of the new angiotensin I-converting enzyme inhibitor, enalapril maleate, on blood pressure, plasma renin, aldosterone and kinins in hypertensive patients].
    Gotoh M, Mizuno K, Hashimoto S, Kunii N, Fukuchi S.
    Nihon Naibunpi Gakkai Zasshi; 1985 May 20; 61(5):619-29. PubMed ID: 2991035
    [Abstract] [Full Text] [Related]

  • 5. Effect of dietary sodium on angiotensin-converting enzyme (ACE) inhibition and the acute hypotensive effect of enalapril (MK-421) in essential hypertension.
    Jackson B, Cubela R, Johnston CI.
    J Hypertens; 1984 Aug 20; 2(4):371-7. PubMed ID: 6099390
    [Abstract] [Full Text] [Related]

  • 6. Humoral and renal effects of MK-421 (enalapril) in hypertensive subjects.
    de Leeuw PW, Hoogma RP, van Soest GA, Tchang PT, Birkenhäger WH.
    J Cardiovasc Pharmacol; 1983 Aug 20; 5(5):731-6. PubMed ID: 6195458
    [Abstract] [Full Text] [Related]

  • 7. Enalapril in treatment of hypertension with renal artery stenosis. Changes in blood pressure, renin, angiotensin I and II, renal function, and body composition.
    Hodsman GP, Brown JJ, Cumming AM, Davies DL, East BW, Lever AF, Morton JJ, Murray GD, Robertson JI.
    Am J Med; 1984 Aug 20; 77(2A):52-60. PubMed ID: 6089557
    [Abstract] [Full Text] [Related]

  • 8. Antihypertensive therapy with MK 421: angiotensin II--renin relationships to evaluate efficacy of converting enzyme blockade.
    Biollaz J, Brunner HR, Gavras I, Waeber B, Gavras H.
    J Cardiovasc Pharmacol; 1982 Aug 20; 4(6):966-72. PubMed ID: 6185790
    [Abstract] [Full Text] [Related]

  • 9. Hemodynamic and antihypertensive effects of the new oral angiotensin-converting-enzyme inhibitor MK-421 (enalapril).
    Fouad FM, Tarazi RC, Bravo EL, Textor SC.
    Hypertension; 1984 Aug 20; 6(2 Pt 1):167-74. PubMed ID: 6327515
    [Abstract] [Full Text] [Related]

  • 10. Captopril versus enalapril maleate: a comparison of antihypertensive and hormonal effects.
    Lewis RA, Baker KM, Ayers CR, Weaver BA, Lehman MR.
    J Cardiovasc Pharmacol; 1985 Aug 20; 7 Suppl 1():S12-5. PubMed ID: 2580164
    [Abstract] [Full Text] [Related]

  • 11. Comparison of blood pressure and angiotensin responses to the renin inhibitor Ro 42-5892 and the angiotensin converting enzyme inhibitor enalapril in essential hypertension.
    van den Meiracker AH, Admiraal PJ, Derkx FH, Kleinbloesem C, Man in 't Veld AJ, van Brummelen P, Mulder P, Schalekamp MA.
    J Hypertens; 1993 Aug 20; 11(8):831-8. PubMed ID: 8228207
    [Abstract] [Full Text] [Related]

  • 12. Enalapril and lisinopril in renovascular hypertension--antihypertensive and hormonal effects of two new angiotensin-converting-enzyme (ACE) inhibitors. A preliminary report.
    Karlberg BE, Fyhrquist F, Grönhagen-Riska C, Tikkanen I, Ohman KP.
    Scand J Urol Nephrol Suppl; 1984 Aug 20; 79():103-6. PubMed ID: 6089307
    [Abstract] [Full Text] [Related]

  • 13. Effect of enalapril (MK-421), an orally active angiotensin I converting enzyme inhibitor, on blood pressure, active and inactive plasma renin, urinary prostaglandin E2, and kallikrein excretion in conscious rats.
    Schiffrin EL, Gutkowska J, Thibault G, Genest J.
    Can J Physiol Pharmacol; 1984 Jan 20; 62(1):116-23. PubMed ID: 6143602
    [Abstract] [Full Text] [Related]

  • 14. Effects of enalapril, a new converting enzyme inhibitor, in hypertension.
    Ferguson RK, Vlasses PH, Swanson BN, Mojaverian P, Hichens M, Irvin JD, Huber PB.
    Clin Pharmacol Ther; 1982 Jul 20; 32(1):48-53. PubMed ID: 6282527
    [Abstract] [Full Text] [Related]

  • 15. A comparative pilot study of enalapril, a new converting enzyme inhibitor, and hydrochlorothiazide in essential hypertension.
    Ferguson RK, Vlasses PH, Irvin JD, Swanson BN, Lee RB.
    J Clin Pharmacol; 1982 Jul 20; 22(7):281-9. PubMed ID: 6286734
    [Abstract] [Full Text] [Related]

  • 16. Correlation between angiotensin converting enzyme inhibition and the acute hypotensive response to MK 421 in essential hypertension.
    Jackson B, McGrath BP, Johnston CI.
    Clin Exp Pharmacol Physiol Suppl; 1982 Jul 20; 7():99-104. PubMed ID: 6291832
    [Abstract] [Full Text] [Related]

  • 17. Effects of a new angiotensin-converting enzyme inhibitor, MK 421, in normal men and patients.
    Kono T, Oseko F, Ikeda F, Nakano R, Taniguchi A, Imura H, Endo J.
    Endocrinol Jpn; 1982 Oct 20; 29(5):615-22. PubMed ID: 6303766
    [Abstract] [Full Text] [Related]

  • 18. Enalapril in the treatment of hypertension with renal artery stenosis.
    Hodsman GP, Brown JJ, Cumming AM, Davies DL, East BW, Lever AF, Morton JJ, Murray GD, Robertson I, Robertson JI.
    Br Med J (Clin Res Ed); 1983 Nov 12; 287(6403):1413-7. PubMed ID: 6315126
    [Abstract] [Full Text] [Related]

  • 19. Antihypertensive efficacy of once daily MK-521, a new nonsulfhydryl angiotensin-converting enzyme inhibitor.
    Rotmensch HH, Vlasses PH, Swanson BN, Irvin JD, Harris KE, Merrill DG, Ferguson RK.
    Am J Cardiol; 1984 Jan 01; 53(1):116-9. PubMed ID: 6318543
    [Abstract] [Full Text] [Related]

  • 20. Effects of angiotensin-converting enzyme inhibition on plasma aldosterone concentration, plasma renin activity, and blood pressure in spontaneously hypertensive cats with chronic renal disease.
    Steele JL, Henik RA, Stepien RL.
    Vet Ther; 2002 Jan 01; 3(2):157-66. PubMed ID: 19750747
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.